Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 34, 2012 - Issue 6
Submit an article Journal homepage
168
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis

Arzu Didem YalcinInternal Medicine, Allergy and Clinical Immunology Unit, Antalya Education and Research Hospital, Antalya, TurkeyCorrespondence[email protected]
,
Saadet GumusluDepartment of Medical Biochemistry, Faculty of Medicine, Akdeniz University, Antalya, Turkey
,
Gizem Esra ParlakDepartment of Medical Biochemistry, Faculty of Medicine, Akdeniz University, Antalya, Turkey
,
Atil BisginHuman Gene and Cell Therapy Center of Akdeniz University Hospitals and Clinics, Antalya, Turkey
,
Mustafa YildizDepartment of Internal Medicine, Antalya Education and Research Hospital, Antalya, Turkey
,
Aysegül KargiDepartment of Internal Medicine, Antalya Education and Research Hospital, Antalya, Turkey
&
Reginald M. GorczynskiDivision of Cellular & Molecular Biology, Toronto Hospital, University Health Network, Toronto, ON, Canada
 show all
Pages 1047-1053 | Received 19 Apr 2012, Accepted 24 May 2012, Published online: 28 Jun 2012

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Arzu Didem Yalcin & Ata Nevzat Yalcin. (2021) Future perspective: biologic agents in patients with severe COVID-19. Immunopharmacology and Immunotoxicology 43:1, pages 1-7.
Read now
Arzu Didem Yalcin, Betul Celik & Ata Nevzat Yalcin. (2016) Omalizumab (anti-IgE) therapy in the asthma–COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels. Immunopharmacology and Immunotoxicology 38:3, pages 253-256.
Read now
Seda Tural Onur, Arzu Didem Yalcin, Betul Celik & Saadet Gumuslu. (2015) Evaluation of d-dimer, CXCL8, homocysteine, eosinophil cationic peptide, 25(OH)-vitamin D and immunomodulatory OX-2 levels in allergic patients. Journal of Asthma 52:2, pages 123-127.
Read now
Arzu Didem Yalcin, Aykut Cilli, Atil Bisgin, Ludwig G Strauss & Felix Herth. (2013) Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels. Expert Opinion on Biological Therapy 13:9, pages 1335-1341.
Read now

Articles from other publishers (9)

Natasha A. Winter, Peter G. Gibson, Michael Fricker, Jodie L. Simpson, Peter A. Wark & Vanessa M. McDonald. (2021) Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma. Allergy, Asthma & Immunology Research 13:3, pages 450.
Crossref
Qiping Shi, Zhiwei Lei, Gui Cheng, Dehai Li, Qian Wang, Simin Luo, Hengwen Yang & Haiying Jia. (2018) Mitochondrial ROS activate interleukin‑1β expression in allergic rhinitis. Oncology Letters.
Crossref
Mahmut Dogru, Muhammed Fatih Evcimik & Ahmet Adnan Cirik. (2015) Is neutrophil–lymphocyte ratio associated with the severity of allergic rhinitis in children?. European Archives of Oto-Rhino-Laryngology 273:10, pages 3175-3178.
Crossref
Arzu Didem Yalcin. (2015) Advances in Anti-IgE Therapy. BioMed Research International 2015, pages 1-11.
Crossref
AD Yalcin. (2014) ANTI-Ige: An Overview. Global Journal of Allergy, pages 003-012.
Crossref
Arzu Didem Yalcin. (2014) An Overview of the Effects of anti-IgE Therapies. Medical Science Monitor 20, pages 1691-1699.
Crossref
Reginald M. Gorczynski. (2013) Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients. Medical Science Monitor 19, pages 102-110.
Crossref
Arzu Didem Yalcin, Saadet Gumuslu, Gizem Esra Parlak & Atil Bısgın. (2012) Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis. Medical Science Monitor 18:10, pages CR617-CR621.
Crossref
Arzu D. Yalcin, Atil Bisgin & Reginald M. Gorczynski. (2012) IL-8, IL-10, TGF- , and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment . Mediators of Inflammation 2012, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.